Wilson Sonsini Goodrich & Rosati advised IonQ on the transaction. IonQ (NYSE: IONQ), a leader in quantum computing, announced that it has reached a definitive agreement...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. Pure Lithium Corporation, a disruptive Boston-based vertically integrated lithium metal battery technology company, announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised GC Therapeutics on the transaction. GC Therapeutics (GCTx), a biopharmaceutical company, announced its launch and the completion of a $65...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. Pure Lithium announced it secured $15 million in a Series A financing led by Oxy Low...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ThayerMahan, Inc. on the transaction. ThayerMahan, Inc. announced it closed $20 million in follow-on Series C funding led by Hanwha Asset...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ThayerMahan on the transaction. ThayerMahan, a world leader in autonomous maritime surveillance solutions, announced the closing of a $30 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Fastcase on the transaction. Legal technology companies vLex and Fastcase announced that they are merging. Oakley Capital and Bain Capital Credit agreed to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cognito on the transaction. Neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised IDX on the deal. Kirkland & Ellis counseled L&F Acquisition Corp. (NYSE: LNFA) on the deal. Venable and Ogier represented...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Totient on the deal. AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced the acquisition...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Pinsent Masons advised 4D pharma plc on the deal. 4D pharma plc, a Leeds, UK-based pharmaceutical company leading the development...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Perrone Robotics on the deal. CapStone Holdings, a business incubator and investment group, announced a $10 million equity investment in...
You must be a Standard 1 Year member to access this content.
